This inventor holds 3 USPTO granted patents and 9 published patent applications. Top assignees: University of California, Frontier Medicines Corporation, Novartis Ag. Active years: 2020-2024.
Company Filing History:
3 out of 15,988 
1 out of 2 
1 out of 3,974 
Years Active: 2020-2024
Title: The Innovations of Daniel K Nomura
Introduction
Daniel K Nomura is a prominent inventor based in Walnut Creek, CA (US). He has made significant contributions to the field of biochemistry and molecular biology, particularly in the area of targeted protein degradation and autophagy. With a total of 3 patents to his name, Nomura's work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Nomura's latest patents include groundbreaking work on covalent targeting of E3 ligases. This patent discloses compositions and methods for targeting E3 ligases, specifically focusing on a targeted protein degrader that includes a targeted protein binder and an E3 Ubiquitin ligase binder, such as human RNF4 or human RNF114. Additionally, he has developed methods and compounds for targeted autophagy, which provide innovative approaches to manipulating cellular processes.
Career Highlights
Throughout his career, Daniel K Nomura has worked with esteemed organizations, including the University of California and Novartis AG. His research has garnered attention for its potential applications in drug development and disease treatment. Nomura's expertise in the field has positioned him as a key figure in advancing our understanding of protein interactions and cellular mechanisms.
Collaborations
Nomura has collaborated with notable colleagues, including Carl C Ward and Roberto Zoncu. These partnerships have facilitated the exchange of ideas and fostered innovative research in the realm of biochemistry.
Conclusion
Daniel K Nomura's contributions to the field of biochemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in targeted therapies and our understanding of cellular processes.